BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18362299)

  • 1. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.
    Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.
    Hahn S; Backhaus M; Broecker-Preuss M; Tan S; Dietz T; Kimmig R; Schmidt M; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
    Yildizhan R; Ilhan GA; Yildizhan B; Kolusari A; Adali E; Bugdayci G
    Fertil Steril; 2011 Jul; 96(1):246-50. PubMed ID: 21600576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.
    Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S
    Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome.
    Mellati AA; Sharifi F; Sajadinejad M; Sohrabi D; Mazloomzadeh S
    Scand J Clin Lab Invest; 2012 Feb; 72(1):39-44. PubMed ID: 22023042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R; Kichler J; Calhoun M
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome.
    Chan TF; Tsai YC; Chiu PR; Chen YL; Lee CH; Tsai EM
    Fertil Steril; 2010 Feb; 93(3):869-73. PubMed ID: 19028383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinol-binding protein 4, as a negative acute-phase reactant in polycystic ovary syndrome.
    Güdücü N; Görmüş U; Telatar B; Dünde I
    Minerva Endocrinol; 2014 Dec; 39(4):299-304. PubMed ID: 25371056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.
    Tan BK; Chen J; Lehnert H; Kennedy R; Randeva HS
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2764-72. PubMed ID: 17456573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: retinol-binding protein 4 and ectopic fat deposition.
    Sopher AB; Gerken AT; Blaner WS; Root JM; McMahon DJ; Oberfield SE
    Fertil Steril; 2012 Apr; 97(4):1009-15. PubMed ID: 22341881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.
    Hutchison SK; Harrison C; Stepto N; Meyer C; Teede HJ
    Diabetes Care; 2008 Jul; 31(7):1427-32. PubMed ID: 18390799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Livadas S; Kandarakis SA; Papassotiriou I; Margeli A
    J Endocrinol Invest; 2008 Nov; 31(11):950-5. PubMed ID: 19169049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.
    Karakas SE; Banaszewska B; Spaczynski RZ; Pawelczyk L; Duleba A
    Gynecol Endocrinol; 2013 May; 29(5):483-7. PubMed ID: 23480783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.